MedPath

Phase II study of R-mini CHP for elderly patients with diffuse large B cell lymphoma

Phase 2
Recruiting
Conditions
diffuse large B cell lymphoma
Registration Number
JPRN-UMIN000011234
Lead Sponsor
Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1.presence of active infeciton 2.presence of central nervous invasion 3.past history of glaucoma. 4.past history of severe drug allergy. 5.HIV Ab positive or HTLV-1 Ab positive. 6.HBsAg positive or HCV Ab positive. 7.severe cardiac disease 8.hepatic cirrhosis 9.uncontrollable diabetis melitus 10.patients with dialysis 11.lung fibrosis or interstitial pneumonitis 12.other active malignancies 13.pregnant or feeding female 14.severe mental disorder 15.continuous systemic administration of steroid 16.judged for inappropriate with other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
2-year progression free survival
Secondary Outcome Measures
NameTimeMethod
2-year over all survival, (complete) remission rate, safety, incidence of febrile neutropenia
© Copyright 2025. All Rights Reserved by MedPath